Showing results (121-130 of 174) with videos related to
Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancerAngelo Di Leo, Henry L Gomez, Zeba Aziz, et al.Molecular Oncology|January 28, 2014
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancersBalázs Győrffy, Giulia Bottai, Jacqueline Lehmann-Che, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2019
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFTOlivia Pagani, Prudence A Francis, Gini F Fleming, et al.Breast Cancer Research and Treatment|March 29, 2018
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00Elisabetta Munzone, Kathryn P Gray, Caterina Fumagalli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice GuidelineAnn H Partridge, R Bryan Rumble, Lisa A Carey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98Sherene Loi, Nicolas Sirtaine, Fanny Piette, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd TrialAmelia McCartney, Martina Bonechi, Francesca De Luca, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the Belgian multicentre studyEvandro de Azambuja, Marianne Paesmans, Marc Beauduin, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 4, 2017
Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric ToolsLaura Biganzoli, Anna Rachelle Mislang, Samantha Di Donato, et al.European Journal of Cancer (Oxford, England : 1990)|May 7, 2019
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)Amelia McCartney, Chiara Biagioni, Gaia Schiavon, et al.Pageof 18